Credits: Kate Shemirani, Facebook & Mediscape UK
"My sister has passed away as a direct consequence of my mum's actions and beliefs and I don't want anyone else to go through the same pain or loss that I have," said Sebastian, son of anti-vaxxer and a British conspiracy theorist Kate Shemirani, whose daughter passed away from cancer at the age of 23.
Sebastian blames his mother and her beliefs to have influencing his sister into not taking proper cancer treatment. Kate, now an anti-vaccine activist and former nurse, had lost her license to practise in 2020 for misconduct and is best known for promoting conspiracy theories about COVID-19 vaccinations and 5G technology.
Her daughter, Paloma Shemirani passed away last July from a type of blood cancer when she was only 23. As per her brother's claim, it is the mother who is to be blamed. However, Kate and her husband wrote to the BBC, claiming that they have evidence against the NHS for her daughter's death. The BBC reports: "'Paloma died as a result of medical interventions given without confirmed diagnosis or lawful consent'. The BBC has seen no evidence to substantiate these claims."
Her brothers, Gabriel and Sebastian, allege that Paloma ultimately declined conventional chemotherapy—despite doctors giving her an 80% chance of survival—due to pressure from their mother, with whom she was trying to rebuild a strained relationship.
They further claim their mother deliberately isolated Paloma from her friends, boyfriend, and extended family, even as her cancer visibly worsened. Paloma, a Cambridge graduate who once celebrated top exam results with a bright smile, had dreamed of a career in publishing.
But her life, her brothers say, was tragically cut short under the undue influence of their mother, who gained notoriety during the pandemic.
In 2023, when Paloma was diagnosed with cancer, doctors informed her she had an 80% chance of recovery if she underwent chemotherapy. But her mother, as reported by the Daily Mail, strongly opposed the treatment.
In a message sent in all capital letters to Paloma’s boyfriend, she warned: “TELL PALOMA NOT TO SIGN IR (sic) VERBALLY CONSENT TO CHEMO OR ANY TREATMENT.”
Despite medical advice and growing concerns about her mother’s influence, Paloma declined chemotherapy. Instead, she turned to one of Kate’s former partners, who encouraged her to consider Gerson therapy — a debunked alternative treatment that promotes a strict plant-based diet and coffee enemas as a cure for cancer, which Kate, too, has claimed, helped in curing her breast cancer.
Cancer Research UK states there is “no scientific evidence” supporting Gerson therapy as an effective cancer treatment. The charity notes that while some people turn to it in search of control over their illness, no credible clinical studies support its use, and existing research is often biased or funded by pro-alternative medicine groups.
Kate’s former partner told the BBC that “any assertions that I played a role in her death are legally inaccurate.”
As Paloma pursued this alternative path, friends began to notice her condition deteriorating, as reported in the Daily Mail. New lumps were appearing, and her cancer was visibly spreading. She reportedly distanced herself from anyone who questioned her treatment decisions.
Her school friend Chantelle shared, “I don’t think her ideology was strong enough to make those decisions. People have different opinions, but I believe her mum played a massive, massive role in it.”
Gabriel, one of Paloma’s brothers, attempted to visit her but was told she couldn’t go outside due to “bad air.” He initiated legal proceedings to have her properly medically evaluated, but the case never moved forward. Paloma died in July 2024 after suffering a heart attack caused by her tumour. She was taken off life support after several days in the hospital.
Gabriel only learned of her death days later through his lawyer and had to inform their brother, Sebastian.
An inquest into Paloma’s death is scheduled to begin next month.
Now 60, she calls herself a 'natural nurse', even though she has been banned from practising nursing in the UK. She also made headlines during the pandemic when she used her social media account to claim that COVID-19 vaccines had a 'tiny bit of Satan' inside, and claims like the jabs caused cancer and contained material harvested from aborted fetuses.
She also claimed that the COVID-19 virus was connected to the rollout of 5G technology and described it as a political tool designed to alter people’s DNA. She compared lockdowns to the Holocaust, declared that NHS nurses seen dancing would one day “stand trial for genocide,” and labelled vaccination teams as “death squads.”
As of now, she has not commented on her sons' claims.
Sebastian has previously described his childhood as “hell,” claiming he was subjected to years of brainwashing. He recalled being terrified at age 10 when Shemirani told him that "the Rothschilds plan to live on a space station" and that a mass genocide was imminent.
In 2012, Kate was diagnosed with breast cancer and underwent surgery, including a double mastectomy and reconstruction. However, online she attributed her recovery not to medical treatment, but to ‘Gerson therapy’—a debunked alternative approach promoting a strict plant-based diet, alongside vitamin and mistletoe injections.
"I'm still here and thriving. You can shove your poison mustard gas where the sun doesn't shine, you pimps and assassins," she posted on X earlier this year, referring to chemotherapy.
According to Chantelle, as reported by Daily Mail, a school friend of Paloma’s, Kate’s belief that conventional medicine had failed only deepened after her recovery. She recounted watching Paloma get sunburned because she refused to wear sunscreen, believing it—not sun exposure—caused cancer.
While Gabriel and Sebastian are now estranged from their mother, Paloma maintained contact, seemingly in an effort to repair their relationship. Like her mother, she also declined the COVID-19 vaccine.
Credits: Novo Nordisk
Global pharma giant Novo Nordisk launched its blockbuster weight loss drug Wegovy in India, a pivotal moment in the battle against increasing obesity levels in the nation. This follows closely on the heels of Eli Lilly's Mounjaro launch in India.
Wegovy, the semaglutide-based GLP-1 receptor agonist, will be available by the end of the month across major pharmacy chains in India. The once-weekly injectable prescription drug has already changed the landscape of obesity management in the United States and Europe.
"One out of every three patients attain 20% weight loss using the increased dose of Wegovy," stated Vikrant Shrotriya, Managing Director, Novo Nordisk India. The firm has completed late-stage trials involving 3,500 people in India, indicating encouraging results in sustained weight loss.
Wegovy will come in several dosages, ranging from Rs 4,336 for 0.25 mg to Rs 26,015 for the highest 2.4 mg dose. Its price is comparable to its rival Mounjaro, which was also launched in India last month in March.
Wegovy is timely given the increasing weight problem in India. A recent National Family Health Survey reveals that 24% of Indian women and 23% of Indian men aged between 15 and 49 years are overweight or obese—a notable increase from past years. India, with a population of over 1.4 billion and fast-emerging lifestyle diseases, is a huge market for weight-loss medications.
The medication has already proven to be successful across the world. Clinical trials have indicated that Wegovy consumers would lose around 15% of their body weight on average, especially when combined with a balanced diet and regular exercise. For comparison, Mounjaro (tirzepatide), being a dual GIP and GLP-1 agonist, experienced close to 23% of weight loss under the same circumstances.
Novo Nordisk's launch in India is at a time of corporate leadership transition, following the recent resignation of CEO Lars Fruergaard Jorgensen. The move is said by analysts to be intended to protect market share in a competitive environment rising from Lilly competition as well as Indian generic drugmakers who are gearing up to move into the field of obesity drugs when semaglutide's patent is about to end in 2026.
Although Wegovy brings new hope to millions of people with obesity, there are warnings with the medication. The drug has a boxed FDA warning about the potential for thyroid cancer, as suggested by studies on animals. Because of this, the drug is not approved for use in someone with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2).
As India joins the global fight against obesity with cutting-edge therapies, India is all set to benefit from Novo Nordisk's Wegovy, which is ready to provide a new, science-driven solution for long-term weight management. The competition has already turned hot, and for Indian consumers, it could mean more options, improved results, and a new age of obesity treatment.
(Credit-Stacie Golebiowski)
When Stacie Golebiowski went for her 36-week ultrasound last summer, she knew her baby would be big, but no one was truly ready for just how big. On July 4, 2024, at Orillia Soldiers’ Memorial Hospital (OSMH), Stacie gave birth to her son, Grayson, who weighed a surprising 15 pounds and 10 ounces. This was such an unusual size that it caused a first-ever problem for the hospital staff when trying to record his weight.
Laura Ferris, who helps manage women and children's services at the hospital, explained that when Grayson was born, the nurses found his weight was too high for the Ontario registry system. They actually had to call the registry, which then had to manually update their records – something that had never happened before.
Now, as Grayson gets close to his first birthday, he's doing great. Stacie shared that there were difficulties and unknowns with Grayson at the start, even for the doctors and nurses. But they got through it all, and he's "doing amazing."
The family hopes their story can help other parents who have unusually large babies. Stacie mentioned feeling like she might have done something wrong, but she emphasized that it's important for parents to understand that it's just what their body does and it's not their fault. According to BORN Ontario, Grayson's birth weight puts him in the top 0.01 percent of all babies born in the province.
According to MedlinePlus, when babies are born larger than average, it's called having a high birth weight. While every baby is a blessing, being very big can sometimes come with a few challenges. For example, it can make the delivery more difficult for both the baby and the mother, and there might be a higher chance of minor injuries during birth. After birth, bigger babies might also face some specific health issues like,
Sometimes, these babies can have trouble with their breathing, requiring extra care.
This is a common condition that causes a yellowing of the skin and eyes because of too much bilirubin in the blood. While many babies get jaundice, those with a high birth weight might be more prone to it or have a more noticeable case.
The Standford Medicine Children’s Health points out that many large babies are born to mothers with diabetes. They also list the risks that are associated with high birth weight,
According to a 2021 study published in the Frontiers in Pediatrics journal, more and more children are being born with high birth weight or are considered "large for gestational age" (LGA). This is happening even more with babies conceived through certain fertility treatments like frozen embryo transfer (FET). While we know a lot about the short-term risks for these babies, less is known about their health in the long run.
A 2021 study looked at the connection between high birth weight and long-term health in children. After reviewing many studies, it found that being born with a high birth weight or LGA was linked to a slightly higher risk for certain cancers in childhood (including breast cancer), some mental health conditions, high blood pressure in childhood, and both type 1 and type 2 diabetes.
Credits: Canva
The season is again transitioning, from spring to summers and some areas are also seeing early monsoons. This is also the allergy season in the US, and thanks to global warming, it has begun earlier. This has caused 25% of adults and 20% of children to experience seasonal allergies. While almost everywhere in America seasonal allergies are going on, there are certain regions where cases are more. You may be more prone to catching diseases. A recent 2025 report by the Asthma and Allergy Foundation of America ranked the 100 most populous metropolitan areas in the contiguous United States based on tree, grass, and weed pollen counts. The data also accounts for number of allergy specialists and estimates of over-the-counter sinus and allergy medication usage.
Each city was scored based on the three factors, and the scores would top out of 100.00 for the worst city for allergies to 45.29 for the best.
Each metropolitan area was also rated as “worse than average,” “average,” or “better than average” based on its levels of tree, grass, and weed pollen. Similar ratings were given for medication usage and access to allergy specialists.
10. At number 10 is Greensboro, North Carolina with a score of 82.08. The pollen rating for this region is worse than average.
9. At number 9 is Greenville, South Carolina with a score of 82.74, and rating worse than average.
8. Next up is Richmond in Virginia, with a score of 82.80. Rating for this too is worse than average.
7. The rating for all is worse than average, and on number 7 is Raleigh, North Carolina, with scoring of 82.87.
6. Little Rock in Arkansas scored 82.94.
5. Memphis in Tennessee scored 83.50.
4. At number 4 is Tulsa in Oklahoma with allergy score of 84.16.
3. For the top 3, we again have Oklahoma with Oklahoma City with allergy score of 86.05.
2. Top 2 is New Orleans in Louisiana, scoring 86.81.
1. For top 1, Wichita in Kansas has scored an allergy score of 100.00.
As per the American College of Allergy, Asthma, & Immunology, in many parts of the United States, spring allergies kick off as early as February and can last through early summer. Tree pollen is typically the first to appear, followed by grass pollen later in the season, and then ragweed, which dominates in late summer and fall. In tropical regions, grass pollen can linger for much of the year. Warmer winter temperatures may trigger early pollination, while a rainy spring often leads to fast plant growth and a spike in mold—prolonging allergy symptoms well into the fall.
Ragweed is the most common cause of fall allergies. It grows wild across the U.S., especially along the East Coast and throughout the Midwest. Ragweed typically starts releasing pollen in August and continues through November, with levels peaking in early to mid-September in many regions.
The intensity and timing of allergy seasons can vary by location, but several climate-related factors play a role in how severe your symptoms may be:
© 2024 Bennett, Coleman & Company Limited